drugset / Trial / NCT00519753

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

NCT00519753

Phase 4 Completed 522 enrolled Alcon Research
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of transitioning uncontrolled glaucoma patients to DuoTrav from other mono or adjunctive therapies.

Timeline

Start
2007-08
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Other
Subject Travoprost Other / unclassified 0.004 % Other

Indications